期刊文献+

男女精神分裂症患者的用药差异

Differences in Male and Female Patients with Schizophrenia Medication
下载PDF
导出
摘要 目的了解男女精神分裂症患者用药的种类和剂量差异,为以后的临床合理用药提供相关依据。方法从2009年l~12月我院住院3个月以上的160例精神分裂症患者,其中男性精神分裂患者82例,女性患者78例为对象,进行对比分析。结果男性患者利培酮51例(62.20%)、阿立派唑13例(15.85%)、氯氮平10例(12.20%)、奥氮平8例(9.75%);女性精神分裂患者:利培酮31例(39.74%)、阿立派唑32例(41.02%)、舒必利12例(15.38%)、奥氮平3例(3.85%)。结论男女精神分裂症患者,在用药上首选利培酮。女患者的用药剂量略大于男患者,阿立派唑在女性患者的用量也较大,但没有显著差别。 Objective To understand the types of male and female patients with schizophrenia medication and dose differences in the clinical use of drugs for later provide evidence.Methods From 2009 l~12 hospitalized more than three months our hospital 160 patients with schizophrenia,in which 82 patients with schizophrenic male,78 cases of women as objects,were analyzed.Results Male patients with risperidone,51 patients(62.20%),A Leekpai azole in 13 cases(15.85%),clozapine in 10 patients(12.20%),olanzapine in 8 cases(9.75%);female patients with schizophrenia:Lee Pei-ketone 31(39.74%),A Leekpai yl 32(41.02%),sulpiride 12(15.38%),3 cases of olanzapine(3.85%).Conclusion The male and female patients with schizophrenia,the first choice in medication risperidone.Slightly larger than the female patients the dose of male patients,A Leekpai azole in the amount of female patients is also larger,but no significant difference.
出处 《中外医疗》 2011年第11期42-42,44,共2页 China & Foreign Medical Treatment
关键词 精神分裂症 药物种类 用药剂量 Schizophrenia Drug type Dosage
  • 相关文献

参考文献4

二级参考文献21

  • 1陆明康,殷美莉,周金娣,彭英芳,郭丽华,刘倩,张良栋.抗精神病药物致粒细胞缺乏症42例分析[J].中华神经科杂志,1994,27(4):252-252. 被引量:13
  • 2司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 3Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
  • 4Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
  • 5Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
  • 6Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
  • 7Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.
  • 8Conley RR, Love RC, Kelly DL, et al. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry, 1999, 156:863-868.
  • 9Meltzer H.Side effects of antipsychotic medications: physician's choice of medication and patient compliance[editorial]. J Clin Psychiatry, 2000, 61 Suppl 8:3-66.
  • 10McCombs JS, Nichol MB, Stimmel GL, et al. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry, 1999, 60 Suppl 19:5-11.

共引文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部